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In Silico Modeling of Coronavirus Disease 
2019 Acute Respiratory Distress Syndrome: 
Pathophysiologic Insights and Potential 
Management Implications
Anup Das, PhD1; Sina Saffaran, PhD1; Marc Chikhani, FFICM2; Timothy E. Scott, PhD3,4; Marianna Laviola, PhD5; 
Nadir Yehya, MD6; John G. Laffey, MD7,8; Jonathan G. Hardman, PhD2,5; Declan G. Bates, PhD1
Objectives: Patients with coronavirus disease 2019 acute respira-
tory distress syndrome appear to present with at least two distinct 
phenotypes: severe hypoxemia with relatively well-preserved lung 
compliance and lung gas volumes (type 1) and a more conventional 
acute respiratory distress syndrome phenotype, displaying the typical 
characteristics of the “baby lung” (type 2). We aimed to test plausible 
hypotheses regarding the pathophysiologic mechanisms underlying 
coronavirus disease 2019 acute respiratory distress syndrome and to 
evaluate the resulting implications for ventilatory management.
Design: We adapted a high-fidelity computational simulator, pre-
viously validated in several studies of acute respiratory distress 
syndrome, to: 1) develop quantitative insights into the key patho-
physiologic differences between the coronavirus disease 2019 acute 
respiratory distress syndrome and the conventional acute respiratory 
distress syndrome and 2) assess the impact of different positive end-
expiratory pressure, Fio2, and tidal volume settings.
Setting: Interdisciplinary Collaboration in Systems Medicine Research 
Network.
Subjects: The simulator was calibrated to represent coronavirus dis-
ease 2019 acute respiratory distress syndrome patients with both 
normal and elevated body mass indices undergoing invasive mechan-
ical ventilation.
Interventions: None.
Measurements and Main Results: An acute respiratory distress syn-
drome model implementing disruption of hypoxic pulmonary vasocon-
striction and vasodilation leading to hyperperfusion of collapsed lung 
regions failed to replicate clinical data on type 1 coronavirus disease 
2019 acute respiratory distress syndrome patients. Adding mecha-
nisms to reflect disruption of alveolar gas-exchange due to the effects 
of pneumonitis and heightened vascular resistance due to the emer-
gence of microthrombi produced levels of ventilation perfusion mis-
match and hypoxemia consistent with data from type 1 coronavirus 
disease 2019 acute respiratory distress syndrome patients, while pre-
serving close-to-normal lung compliance and gas volumes. Atypical 
responses to positive end-expiratory pressure increments between 5 
and 15 cm H2O were observed for this type 1 coronavirus disease 
2019 acute respiratory distress syndrome model across a range 
of measures: increasing positive end-expiratory pressure resulted 
in reduced lung compliance and no improvement in oxygenation, 
whereas mechanical power, driving pressure, and plateau pressure all 
increased. Fio2 settings based on acute respiratory distress syndrome 
network protocols at different positive end-expiratory pressure levels 
were insufficient to achieve adequate oxygenation. Incrementing tidal 
volumes from 5 to 10 mL/kg produced similar increases in multiple 
indicators of ventilator-induced lung injury in the type 1 coronavirus 
disease 2019 acute respiratory distress syndrome model to those 
seen in a conventional acute respiratory distress syndrome model.
Conclusions: Our model suggests that use of standard positive 
end-expiratory pressure/Fio2 tables, higher positive end-expiratory 
pressure strategies, and higher tidal volumes may all be potentially 
deleterious in type 1 coronavirus disease 2019 acute respiratory 
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distress syndrome patients, and that a highly personalized approach 
to treatment is advisable.
Key Words: acute respiratory distress syndrome; coronavirus disease 
2019; mechanical ventilation; ventilator-induced lung injury
Coronavirus disease 2019 (COVID-19) has challenged the global community with a novel disease that is currently not fully understood. As well as the elderly, it has a predilection 
for the comorbid, particular ethnicities, and the obese. Coronavirus 
disease 2019 acute respiratory distress syndrome (CARDS) appears 
to have a dynamic time-related disease spectrum with at least two 
proposed “phenotypes”: a type 1 phenotype (nontypical acute 
respiratory distress syndrome [ARDS]), characterized by near-
normal lung compliance and pulmonary gas volume, combined 
with large shunt fraction and severe hypoxemia (1–3), which may 
evolve into or exist alongside, and a type 2 phenotype characterized 
by a lower lung compliance (“baby lung” [4]) and a general clinical 
presentation more typical of severe ARDS. Pulmonary microvas-
cular thrombosis and associated ischemic events also appear to be 
a particular characteristic of the disease (3).
It is currently unclear whether transitions from the type 1 to 
type 2 phenotype are due to the natural evolution of the disease, 
or to the damage to the lung resulting from inappropriate initial 
ventilatory management leading to a cycle of progressively injuri-
ous ventilator-induced lung injury (“VILI vortex”) (5, 6), or to a 
combination of the two. Wide variations in mortality rates across 
different ICUs, together with unexpected patient responses to 
usual guidelines for ventilatory management, have led some cli-
nicians to assert that standard ventilation protocols employing 
positive end-expiratory pressure (PEEP)/Fio2 tables, “open lung” 
targets, etc. may need significant revision and selective application 
of their components in CARDS patients (6). A primary concern is 
that pathophysiologic changes underlying “classical” ARDS ven-
tilation approaches may not apply in some CARDS patients and 
may thereby lead to ventilator-induced injury, as represented by 
the conversion of patients from the type 1 to type 2 phenotypes. 
For example, the use of relatively high PEEP in ARDS treatment 
is based on the assumption that hypoxemia is due to recruitable 
nonaerated lung regions; however, in the type 1 CARDS patient, 
the lung units may be open but nonfunctional due to vascu-
lar shunt, and thus PEEP may overdistend (rather than recruit) 
these lung units, leading to injury without any improvement in 
gas exchange. The avoidance of VILI in CARDS patients is also of 
particular importance given the extended time periods for which 
many of these patients receive mechanical ventilation.
Based on the insights gained from clinical experience, hypoth-
eses have been put forward to explain the particular pathophysi-
ologic characteristics of CARDS patients. Gattinoni et al (1, 2) 
have proposed pulmonary vasoparesis (i.e., globally reduced pul-
monary vascular tone) resulting from impaired regulation of lung 
perfusion and disruption of hypoxic pulmonary vasoconstriction 
(HPV) as a possible explanation for the severe hypoxemia occur-
ring in the compliant lungs of type 1 patients, whereas results in 
(7–9) indicate a potentially important role for endothelial damage 
due to pneumonitis and microthrombi. However, there is currently 
no direct evidence with which to evaluate quantitatively the effect 
on gas exchange and ventilation perfusion (V/Q) mismatch of 
each of these mechanisms, alone or in combination. The clinical 
evaluation of alternative ventilation strategies for CARDS based 
on hypothesized models of its pathophysiology is also extremely 
difficult in the current circumstances.
To shed light on the above issues, we employed a multicom-
partmental computational model that simulates highly inte-
grated pulmonary and cardiovascular physiologies together with 
a detailed representation of the effects of invasive mechanical 
ventilation. This model has been successfully deployed in several 
previous studies investigating the pathophysiology and ventilatory 
management of conventional ARDS (10–16). In this study, we use 
this model to simulate proposed pathophysiologic mechanisms 
underlying CARDS, by altering key variables to create exemplar 
patients that reproduce the currently available clinical data. The 
biomechanics and physiology of obesity are readily amenable to 
study within this model, and so we include an exemplar patient 
from this at-risk group. We then use these models to compare the 
effects of different ventilator settings for CARDS and conventional 
ARDS patients.
MATERIALS AND METHODS
Cardiopulmonary Computational Model
The study employs a multicompartmental computational model 
that simulates a dynamic in vivo cardiovascular-pulmonary state, 
comprising conducting airways and a respiratory zone of 100 par-
allel alveolar compartments, with each compartment having an 
independent set of variables accounting for stiffness, threshold 
opening pressures (TOPs), and extrinsic pressures that compress 
the alveolus as well as airway and perialveolar vascular resistances. 
This allows for a wide spectrum of ventilation-perfusion mis-
match to be replicated. The model includes inherent physiologic 
reflex mechanisms, for example, HPV. The capability of the simu-
lator to represent the cardiopulmonary disease states of individual 
patients with ARDS has been validated in a number of previous 
studies (10–16), and the mathematic and physiologic principles 
on which it is based are detailed in the Supplementary Material, 
http://links.lww.com/CCX/A295.
Measurements of Key Physiologic Variables and VILI 
Indices From the Model
Mechanical ventilation in the model is set to pressure-con-
trolled mode with respiratory rate at 20 beats/min, inspiratory-
to-expiratory ratio at 1:2, and Fio2 set to 100%. To observe the 
cardiopulmonary effects of interest, the following values were 
computed and recorded: Pao2, Paco2, arterial pH, arterial oxy-
gen saturation (Sao2), mixed venous oxygen saturation, volume 
of individual alveolar compartments at end-inspiration (Valv_insp), 
volume of individual alveolar compartments at end-expiration 
(Valv_exp), pressure of individual alveolar compartments at end-
inspiration (Palv_insp), pressure of individual alveolar compartments 
at end-expiration (Palv_exp), cardiac output (CO), mean arterial 
pressure, mean pulmonary artery pressure, and arterial oxygen 
delivery (Do2; computed using the values of CO, Sao2, and Pao2 
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and hemoglobin level). Alveolar recruitment was calculated as 
the fraction of alveoli receiving zero ventilation and subsequently 
achieving ventilation. VILI indices calculated include respiratory 
system compliance, intratidal recruitment, mechanical power 
(16), driving pressure, mean alveolar pressure, and dynamic strain 
(calculated as ∆V/Vfrc, where Vfrc is Valv_exp at PEEP = 0 cm H2O and 
∆V = Valv_insp–Valv_exp).
Intratidal recruitment was calculated as the difference between 
the ratio of total ventilated lung at the end of inhalation to that at 
the end of exhalation. Shunt fraction (QS/QT) was calculated using 
the shunt equation, based on the arterial, pulmonary end-capil-
lary, and mixed venous oxygen content. Physiologic dead space 
volume and tidal volume (Vd/Vt) were calculated from Paco2, 
mixed expired co2 tension, and exhaled Vt (17). PEEPTOT is mea-
sured as the total pressure within the lung at the end of expiration 
and accounts for both the extrinsic applied expiratory pressure 
and intrinsically generated end-expiratory pressures. Plateau pres-
sure (Pplat) is measured as the average end-inspiratory pressure 
in the lung. Lung compliance is calculated as ∆V/∆P, where ∆P is 
the Pplat minus PEEPTOT. All simulations were run for 30 minutes, 
and during simulations, all variables were updated and recorded 
every 10 ms.
RESULTS
Pathophysiologic Mechanisms That Produce a Type 1 
CARDS Phenotype
We configured the simulator’s baseline settings to represent two 
“exemplar” patients—a typical (ideal body weight) 70-kg patient 
and an obese patient weighing 110 kg (body mass indices [BMIs] 
24 and 37.7 kg/m2, respectively). Patients were assumed to be 
sedated and to be receiving positive pressure mechanical ventila-
tion without any spontaneous ventilatory effort.
The exemplar patient models were then configured according 
to clinical data on different CARDS phenotypes available in the 
literature. Based on the data (1–6) suggesting that type 1 CARDS 
patients have relatively well-preserved lung gas volume and com-
pliance, the type 1 models were set to have 8% (11% in patients 
with elevated BMI) of their alveoli collapsed, that is, nonaerated, 
with low recruitability (i.e., extrinsic pressures acting on collapsed 
alveolar compartments were set to greater than 40 cm H2O with 
average TOPs of 50 cm H2O) (1–4). To simulate the hyperperfu-
sion of gasless tissue reported in the study by Gattinoni et al (1), 
we implemented vasodilation in the collapsed units by decreasing 
their vascular resistance by 80%. HPV is normally incorporated 
in our simulator via a mathematic function, based on the stim-
ulus-response curve suggested in (18); to simulate the hypothe-
sized disruption of HPV in CARDS, we disabled this function in 
our model. Simulating the effects of these mechanisms alone did 
not produce levels of QS/QT, dead space, and hypoxemia match-
ing those reported in clinical data describing type 1 CARDS 
(Table 1). We, therefore, also incorporated disruption of alveolar 
gas-exchange due to the effects of pneumonitis into the model by 
blocking alveolar-capillary gas equilibration in 30% of the alveolar 
compartments. As thrombotic complications have been reported 
to be a characteristic feature of CARDS, we modeled the presence 
of microthrombi by increasing vascular resistance by a factor of 
100 in 10 of the 30 compartments with disrupted gas exchange. 
Implementing the above additional pathophysiologic mecha-
nisms in our model produced levels of QS/QT (47.8%), dead space 
(192.3 mL), and hypoxemia (Sao2 87.6% and Fio2 of 100%) that 
match those reported in clinical data describing type 1 CARDS 
(1–6), while still preserving near-normal levels of lung compliance 
(43.5 mL/cm H2O) (Table 1).
Although a reasonable assumption, there is currently no clear 
evidence that pulmonary vascular microthrombi primarily arise 
in alveoli that have been damaged by pneumonitis, and therefore, 
we also modeled the effect of microthrombi being heterogeneously 
distributed throughout the lung, by increasing vascular resistance 
in five of the disrupted and five of the normally functioning com-
partments. This further worsened V/Q matching (QS/QT increased 
to 51.8% and dead space to 205.9 mL) leading to severe hypoxemia 
(Sao2 83.8% and Fio2 of 100%) (Table 1).
For the purposes of comparison, both normal and elevated 
BMI patients were also configured to represent a conventional 
ARDS phenotype (3, 4). Specifically, the compliance and TOPs of 
50 alveolar compartments were configured to create nonaerated 
(at baseline) but recruitable lung regions (extrinsic pressures that 
induce collapse, set with a mean value of 20 cm H2O and a mean 
TOP of 20 cm H2O), resulting in a QS/QT of 39%, Vd/Vt of 0.3, 
and compliance of 35.1 mL/cm H2O in the normal BMI model.
Effects of High Versus Low PEEP
Figure 1 shows the results of reducing PEEP to 5 cm H2O and 
increasing PEEP to 15 cm H2O (from a baseline setting of 10 cm 
H2O), while keeping Vt fixed at 7 mL/kg, for both the type 1 
CARDS and conventional ARDS models (normal BMIs). As 
shown, strikingly different responses were observed for the two 
models across a range of measures. For the conventional ARDS 
model, increasing PEEP produced improvements in Do2 and arte-
rial oxygenation (Pao2 and Sao2) resulting from increased alveo-
lar recruitment, increased lung compliance, and reduced shunt, 
with a reduction in driving pressure and only a modest increase 
in mechanical power. In contrast, for the type 1 CARDS model, 
increasing PEEP reduced Do2, produced no improvement in 
oxygenation, and reduced lung compliance, whereas mechanical 
power, driving pressure, and Pplat were all increased. In the obese 
type 1 CARDS patient, increasing PEEP did slightly increase Do2 
and arterial oxygenation, but to a lesser extent than in the conven-
tional ARDS model; see Figure S1 in the Supplementary Material, 
http://links.lww.com/CCX/A295. Corresponding results in terms 
of relative changes, rather than absolute values, for both figures are 
shown in Figures S2 and S3 of the Supplementary Material, http://
links.lww.com/CCX/A295.
Effects of Applying Acute Respiratory Distress 
Syndrome Network PEEP/Fio2 Tables
To investigate the utility of applying standard combinations of 
PEEP and Fio2 based on the tables derived from the acute respira-
tory distress syndrome network (ARDSnet) trial (19), we evalu-
ated the effect of varying Fio2 between 0.4 and 1 at the PEEP levels 
of 5 and 10 cm H2O. In the type 1 CARDS model, at a PEEP of 
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TABLE 1. Pathophysiological Mechanisms Generating a Type 1 Coronavirus Disease 2019 Acute 
Respiratory Distress Syndrome Phenotype
Normal BMI Elevated BMI
Type 1 
Phenotype 
(Vasodilation 
HPV Off)
aCollocated  
Pneumonitis and 
Thrombosis
aDispersed Pneumonitis and 
Thrombosis (5% Thrombosis 
in Pneumonitis and 5% 
Thrombosis in Nonpneumonitis 
Compartments)
aCollocated 
Pneumonitis and 
Thrombosis
aDispersed Pneumonitis and 
Thrombosis (5% Thrombosis 
in Pneumonitis and 5% 
Thrombosis in Nonpneumonitis 
Compartments)
Type 1  
Phenotype 
(Pneumonitis 30%, 
Thrombosis  
10%, and 
Vasodilation  
HPV Off)
Type 1  
Phenotype 
(Pneumonitis 
30%, Thrombosis 
10%, and 
Vasodilation  
HPV Off)
Conventional 
ARDS
Type 1  
Phenotype 
(Pneumonitis  
30%, Thrombosis 
10%, and 
Vasodilation  
HPV Off)
Type 1  
Phenotype 
(Pneumonitis 
30%, Thrombosis 
10%, and 
Vasodilation  
HPV Off)
Conventional 
ARDS
Positive end- 
expiratory 
pressure, cm H2O
5 5 5 5 5 5 5
Ventilation rate, 
beats/min
20 20 20 20 20 20 20
Duty cycle 0.33 0.33 0.33 0.33 0.33 0.33 0.33
Fio2 1 1 1 1 1 1 1
Vt, mL 470 470 470 470 490 490 490
Vt, mL/kg 6.7 6.7 6.7 6.7 7.0 7.0 7.0
Peak pressure, cm 
H2O
25 25 25 30 25 25 30
Shunt fraction, % 28.0 47.78 51.79 39.01 52.05 59.75 42.92
Vd, mL 118.3 192.3 205.2 142.9 220.9 234.4 172.8
Vd/Vt 0.25 0.4 0.43 0.3 0.45 0.48 0.35
Respiratory system 
compliance,  
mL/cm H2O
43.6 43.28 43.28 35.05 40.65 39.98 32.03
Arterial oxygen 
saturation, %
96.6 87.6 83.79 90.3 84.18 75.14 87.69
Pao2, kPa 10.9 7.5 6.9 8.42 7.41 6.27 8.36
Ratio of Pao2 to 
Fio2, mm Hg
117.0 56.5 51.75 63.15 55.58 47.02 62.7
Paco2, kPa 4.4 6.1 6.5 6.1 7.9 8.7 8
Cardiac output,  
L/min
6.3 6.21 6.21 6.04 7.81 7.81 7.36
Mean pulmonary 
artery pressure, 
mm Hg
19 20.18 20.18 25.25 23.58 23.57 30.18
Mean arterial 
pressure, mm Hg
108.5 125.32 125.32 123.87 132.91 132.92 128.17
Mechanical power, 
J/min
17.18 17.14 17.14 19.96 17.51 17.25 20.14
Dynamic strain 0.17 0.17 0.17 0.17 0.29 0.28 0.29
Driving pressure, 
cm H2O
12.9 12.9 12.9 16.6 13.8 13.8 17.9
ARDS = acute respiratory distress syndrome, BMI = body mass index, HPV = hypoxic pulmonary vasoconstriction, Vd = dead space volume, Vt = tidal volume.
aThe description of the pathophysiology.
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5 cm H2O, application of an Fio2 of 0.4 (corresponding to the top 
of the range suggested in [19]) is insufficient to produce a level of 
Pao2 exceeding 7.3 kPa (Fig. 2). At a PEEP of 10 cm H2O, applica-
tion of Fio2 of 0.7 as suggested in (19) is also insufficient to ensure 
adequate oxygenation in the type 1 CARDS model. In contrast, 
application of these settings to the conventional ARDS model 
produces Pao2 levels above the 7.3 kPa threshold for both PEEP 
values.
Effects of High Versus Low Vt
Figure 3 shows the results of reducing Vt to 5 mL/kg and increas-
ing Vt to 10 mL/kg (from a baseline setting of 7 mL/kg), while 
keeping PEEP fixed at 10 cm H2O, for both the type 1 CARDS 
and conventional ARDS models (normal BMIs). In this case, 
increased Vt does produce some improvements in gas exchange 
in the type 1 CARDS model, with increased Sao2 and Do2 and 
reduced Paco2, although the improvements are smaller than 
those seen in the conventional ARDS model. Notably, however, 
the associated worsening in VILI indicators (mechanical power, 
driving pressure, dynamic strain, and Pplat) mirrors or exceeds 
that produced in the conventional ARDS model. Increasing Vt 
in the obese models also produced improved gas exchange, but 
again at the cost of clinically significant increases in multiple VILI 
indices; see Figure S4 in the Supplementary Material, http://links.
lww.com/CCX/A295. Corresponding results in terms of relative 
changes, rather than absolute values, for both figures are shown 
in Figures S5 and S6 of the Supplementary Material, http://links.
lww.com/CCX/A295.
DISCUSSION
The modifications required to our conventional ARDS model 
to allow it to reproduce the particular features of type 1 patients 
are consistent with recent data on lung perfusion abnormali-
ties in CARDS patients from imaging and postmortem studies. 
In the study by Lang et al (20), dual-energy CT imaging of three 
CARDS patients revealed preferentially increased perfusion of 
the lungs proximal to areas of lung opacity, decreased areas of 
peripheral perfusion corresponding to peripheral lung opacities, 
and a halo of increased perfusion surrounding peripheral areas 
Figure 1. Results of reducing positive end-expiratory pressure (PEEP) to 5 cm H2O and increasing PEEP to 15 cm H2O (from a baseline setting of 10 cm H2O), 
while keeping tidal volume (Vt) fixed at 7 mL/kg, for both the type 1 coronavirus disease 2019 acute respiratory distress syndrome (CARDS) and conventional 
acute respiratory distress syndrome (ARDS) models (normal body mass index [BMI] patient). CO = cardiac output, Do2 = oxygen delivery, MAP = mean arterial 
pressure, MPAP = mean pulmonary artery pressure, PF = ratio of Pao2 to Fio2, power = mechanical power, Ppeak = peak pressure, Pplat = plateau pressure, 
Sao2 = arterial oxygen saturation, strain = dynamic strain, Vd = dead space volume, ΔP = driving pressure.
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of consolidation. A remarkable level of hyperperfusion of gasless 
tissue was also noted in (1). A postmortem study reported vasodi-
lation of pulmonary vessels in two CARDS patients (21). Finally, 
two recent studies indicated that CARDS patients are prone to 
significant vascular dysfunction (also confirmed by the authors’ 
clinical experience): in the study by Helms et al (7), 64 clinically 
relevant thrombotic complications were diagnosed in 150 CARDS 
patients (including pulmonary embolisms) with greater than 
95% of patients having elevated d-dimer and fibrinogen, whereas 
a postmortem examination of 21 CARDS patients in the study 
by Menter et al (8) reported massive capillary congestion often 
accompanied by microthrombi and pulmonary emboli, despite 
prophylactic anticoagulation.
In our model, we found that implementing pulmonary vasopa-
resis on its own was not sufficient to produce the levels of shunt 
and hypoxia, etc. seen in type 1 patients. However, combining this 
mechanism with pneumonitis-induced disruption of the alveolar-
capillary barrier (as proposed in [9]) and the presence of micro-
thrombi (as reported in [7, 8]) allows the model to produce the 
observed levels of V/Q mismatch and hypoxia, while preserving 
normal lung compliance and gas volumes. Interestingly, analysis 
of data from the LUNG SAFE study (22) indicates that a subset of 
patients with type 1 characteristics (e.g., poor PEEP responsive-
ness) also exists in “classical” ARDS; however, their frequency is 
lower than that seen in CARDS.
Several studies have examined lung recruitability in small 
cohorts of CARDS patients using PEEP titration (23–25). Results 
reveal a wide variation in the level 
of recruitability, consistent with our 
results. Data from these studies sug-
gest that there is potential for PEEP-
induced VILI in nonrecruitable 
CARDS lungs (higher driving pres-
sures due to increased PEEP in [24] 
and reduced compliance in [25]), 
and this is confirmed by the marked 
elevation in multiple VILI indica-
tors in our type 1 CARDS model as 
PEEP is increased from 5 to 15 cm 
H2O. Based on these results, and as 
recently argued in (26), the use of 
high PEEP in type 1 CARDS patients 
does not appear to yield a favorable 
risk/benefit profile; it is, therefore, 
essential to evaluate the recruitabil-
ity of each patient carefully before 
employing a standard ARDSnet low 
Vt/high PEEP strategy. As demon-
strated in Figure  2, application of 
standard ARDSnet type PEEP/Fio2 
tables in type 1 CARDS patients is 
also unlikely to achieve the levels of 
oxygenation typically produced in 
conventional ARDS patients.
It has been asserted that CARDS 
patients may be able to accept larger 
Vts than those now normally applied in lung protective ventilation 
for ARDS without increasing the risk of VILI (5). Our results indi-
cate that use of higher Vt can produce improvements in oxygenation, 
but the observed worsening of VILI indicators raises concerns that 
higher Vt could also damage the type 1 CARDS lung. This may be 
of particular importance given the relatively longer periods for which 
CARDS patients appear to require mechanical ventilation (27). Given 
the stronger association between improved driving pressure and 
outcome (28), relative to improved gas exchange (19), the risks of 
increasing Vt to improve hypoxemia need to be carefully balanced 
against the increased mortality risk due to higher driving pressure.
The application of prone positioning in patients with CARDS 
(whether mechanically or noninvasively ventilated) has, in the 
clinical experience of the authors, a significant beneficial effect on 
the ratio of Pao2 to Fio2 (P/F) and, albeit anecdotally, on patient 
outcomes. Globally, intensive care teams are unlikely to have ever 
simultaneously looked after as many proned patients as they have 
during the COVID-19 outbreak, and arguably, the management of 
such patients combined with the logistical burden this entailed will 
be the hallmark of the period. Already of proven benefit in patients 
with hypoxic respiratory failure (29), prone positioning may have 
an even more pronounced effect in patients requiring mechanical 
ventilation due to CARDS. The maneuver has been so successful, 
at least in the short term, that prone positioning has been extrapo-
lated to spontaneously breathing patients (for the first time in the 
authors’ experience), resulting in, anecdotally, equally impressive 
improvements in oxygenation. Prolonged prone positioning has 
Figure 2. Results of varying Fio2 at positive end-expiratory pressure (PEEP) levels of 5 and 10 cm H2O in both 
the type 1 coronavirus disease 2019 acute respiratory distress syndrome (CARDS) and conventional acute 
respiratory distress syndrome (ARDS) models. ARDSnet = acute respiratory distress syndrome network.
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recently been demonstrated to result in improvements in P/F ratios 
to greater than those recorded preintubation in a small study of 
CARDS patients, with no change in the complication rate (30).
From a physiologic standpoint, quite why proning might be so 
effective in CARDS is not currently understood, particularly in 
the type 1 phenotype, where its use remains controversial (1–5). 
The argument that proning improves V/Q mismatch through 
increasing blood flow to functioning ventral alveoli seems to fall 
short of a full explanation for the significant improvements seen in 
oxygenation in CARDS. While dual-energy CT scanning of such 
patients is technically feasible, it is logistically difficult. Use of a 
physiologic simulator such as that developed here may allow us to 
understand the mechanistic basis for the improvements achieved 
by proning, and potentially guide the timing, duration, and opti-
mization of ventilation for prone positioned CARDS patients.
CONCLUSIONS
A model implementing: 1) vasodilation leading to hyperper-
fusion of collapsed lung regions, 2) disruption of HPV, 3) 
disruption of alveolar gas-exchange due to the effects of pneu-
monitis, and 4) heightened vascular resistance due to the pres-
ence of microthrombi replicates levels of ventilation-perfusion 
mismatch and hypoxemia exhibited by type 1 CARDS patients, 
while preserving close-to-normal lung compliance and gas vol-
umes. Our results suggest that ventilatory management of such 
patients (whether with normal or elevated BMI) should not fol-
low standard protocols, but rather focus on keeping PEEP, and 
where possible Vt, low, in order to avoid the risk of entering the 
VILI vortex.
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Figure 3. Results of reducing tidal volume (Vt) to 5 mL/kg and increasing Vt to 10 mL/kg (from a baseline setting of 7 mL/kg), while keeping positive end-
expiratory pressure (PEEP) fixed at 10 cm H2O, for both the type 1 and conventional acute respiratory distress syndrome (ARDS) models (normal body mass 
index [BMI] patient). CARDS = coronavirus disease 2019 acute respiratory distress syndrome, CO = cardiac output, Do2 = oxygen delivery, MAP = mean arterial 
pressure, MPAP = mean pulmonary artery pressure, PF = ratio of Pao2 to Fio2, power = mechanical power, Ppeak = peak pressure, Pplat = plateau pressure, 
Sao2 = arterial oxygen saturation, strain = dynamic strain, Vd = dead space volume, ΔP = driving pressure.
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